TransCode Therapeutics Inc (NASDAQ:RNAZ) has a beta value of 1.45 and has seen 22.79 million shares traded in the last trading session. The company, currently valued at $11.44M, closed the last trade at $0.49 per share which meant it lost -$0.03 on the day or -5.77% during that session. The RNAZ stock price is -13436.73% off its 52-week high price of $66.33 and -6.12% below the 52-week low of $0.52. If we look at the company’s 10-day average daily trading volume, we find that it stood at 28.12 million shares traded. The 3-month trading volume is 6.72 million shares.
TransCode Therapeutics Inc (NASDAQ:RNAZ) trade information
Sporting -5.77% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the RNAZ stock price touched $0.49 or saw a rise of 36.36%. Year-to-date, TransCode Therapeutics Inc shares have moved -85.46%, while the 5-day performance has seen it change -56.25%. Over the past 30 days, the shares of TransCode Therapeutics Inc (NASDAQ:RNAZ) have changed -80.56%. Short interest in the company has seen 0.34 million shares shorted with days to cover at 0.15.
TransCode Therapeutics Inc (RNAZ) estimates and forecasts
The company’s shares have lost -97.71% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -28.81% over the past 5 years.
RNAZ Dividends
TransCode Therapeutics Inc is expected to release its next earnings report on 2024-Nov-13 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
TransCode Therapeutics Inc (NASDAQ:RNAZ)’s Major holders
Insiders own 0.15% of the company shares, while shares held by institutions stand at 0.67% with a share float percentage of 0.67%. Investors are also buoyed by the number of investors in a company, with TransCode Therapeutics Inc having a total of 11.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Total Market Index Fund . As of Jan 31, 2025 , the former fund manager holds about 0.41% shares in the company for having 2.83 shares of worth $1388.0 while later fund manager owns 1.18 shares of worth $577.0 as of Jan 31, 2025 , which makes it owner of about 0.17% of company’s outstanding stock.
